Contributors
TwentyTwentyTweets
-
Join 7,195 other subscribers
-
Recent Posts
Pages
Category Archives: White Paper
Guest Blogspot: NHS Reforms- What the UK Government Policy Changes Really Mean
There is a strong consensus amongst independent experts, medical professionals and politicians that major NHS reforms are both desirable and inevitable. Healthcare is one of mankind’s greatest priorities. An aging population and medical advances mean that healthcare expenditure is bound … Continue reading
Posted in Andrew Lansley, Business, competition, David Cameron, Department of Health, Drugs, Elderly, GPs, Health Bill, Hospitals, NHS, Policy, Research, White Paper
Tagged 2020health, Andrew lansley, cherry picking, Commissioning, competition, David Cameron, Department of Health, elderly, GP, GPs, health, Health and Social Care Bill, Health Bill, Ipsos MORI, National Health Service, NHS, NHS Reforms, Patients, pricing, Quality, R&D, Research
Leave a comment
Guest Blogspote: How to encourage pharmaceutical R&D
Politicians should only attempt the possible. We must recognise what we cannot do. The UK Government alone cannot influence the direction of R&D significantly. The sums of money involved are so vast that R&D only makes sense in a global … Continue reading
Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, Health Bill, Hospitals, Innovation, NHS, Pharma, Policy, Research, Uncategorized, White Paper
Tagged 2020health, Andrew lansley, biotechnology, breakthrough, Clinical trials, competition, Department of Health, Equity and Excellence, health, Health Bill, medicine, National Health Service, NHS, NICE, patent box, Pfizer, pharmaceutical, pricing, R&D, R&D tax credit, Research, university, value-based, value-based pricing, wholesaler
Leave a comment
Guest Blogspot – NHS Reforms: Health and Social Care Bill 2011
This blog gives my initial thoughts about the eagerly awaited bill presented by Andrew Lansley on Wednesday 19th January. The Government’s plans for the reform of the NHS were generally well received last summer and during the public consultation period … Continue reading
Posted in Andrew Lansley, Department of Health, Drugs, GPs, Health Bill, Inequality, NHS, Pharma, Policy, Primary Care, Research, Technology, Uncategorized, White Paper
Tagged 2020health, Andrew lansley, BMA, Commissioning, Department of Health, Drugs, Equity and Excellence, GP, GPs, health, Health Bill, medicine, NHS, NICE, Responsibility in healthcare, work
Leave a comment
Primary Care reforms and the role of Pharmacists
The London School of Pharmacy launched its New Year’s open discussion about the future of pharmacy in the midst of NHS reforms. This discussion featured a prominent panel of speakers including Professor Sir Nicholas Wald and Dr Panos Kanavos, chief … Continue reading
Guest BlogSpot – Nice Move on Drug Pricing but Where Next?
The Government is reported to favour a system of value-based drug pricing. Value for money is, of course, important whenever public money is spent on anything. Pharmaceuticals are no exception. Discussion about how to obtain the best value from NHS … Continue reading
Posted in Department of Health, Drugs, GPs, Inequality, NHS, Pharma, Policy, Uncategorized, White Paper
Tagged 2020health, Department of Health, Drugs, GPs, health, NHS, NICE, postal lottery, PPRS, prescribing, pricing, value-based
Leave a comment
Liberating the NHS Revisited
The first wave of formal public consultation following last July’s publication of the White Paper “Equity and Excellence: Liberating the NHS” ended over a week ago. Now should be a good time to take stock and reconsider our first impressions. … Continue reading
Posted in Department of Health, Drugs, GPs, Hospitals, Pharma, Policy, Research, White Paper
Leave a comment
EUWTD, White Paper and Nursing, 2020 copies
The Times (£) reports today that 1 in 5 junior doctors are leaving their positions after two years because of the impact of the EUWTD regulations on their training. However the full regulations have only been in place a year, … Continue reading
White Paper Reconciliation 2 and where the Big Society can help
Another Monday, another big announcement. Yesterday’s speech by David Cameron on the Big Society was, like much ideas in the Health White Paper the Monday before, trailed during the General Election but received little publicity in the wake of the … Continue reading
Posted in Andrew Lansley, Demand Reduction, Inequality, White Paper
Tagged Big Society, David Cameron, Equity and Excellence, NHS
Leave a comment
White Paper Reconciliation 1
Last week was an historic one. Most people picked up that something seismic had happened, but weren’t entirely sure what, as enquiries came in from pharmacists to MPs to venture capitalists. We had set out a prescription for success that … Continue reading
You must be logged in to post a comment.